Cathie Wood Beam Therapeutics Inc. Transaction History

Ark Investment Management LLC

$12.1 Billion
Q2 2025

A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Ark Investment Management LLC holds 8,847,841 shares of BEAM stock, worth $149 Million. This represents 1.24% of its overall portfolio holdings.

Number of Shares

8,847,841

Previous 8,480,089 4.34%

Holding current value

$149 Million

Previous $166 Million 9.13%

% of portfolio

1.24%

Previous 1.79%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 30, 2025	BUY	$14.54 - $20.24 $5.35 Million - $7.44 Million	367,752 Added 4.34%	8,847,841 $151 Million
Q1 2025 May 07, 2025	BUY	$19.53 - $34.09 $27.6 Million - $48.1 Million	1,412,060 Added 19.98%	8,480,089 $166 Million
Q4 2024 Feb 04, 2025	BUY	$21.55 - $30.35 $11.6 Million - $16.3 Million	536,930 Added 8.22%	7,068,029 $175 Million
Q3 2024 Oct 31, 2024	SELL	$22.57 - $33.14 $24.7 Million - $36.3 Million	-1,095,040 Reduced 14.36%	6,531,099 $160 Million
Q2 2024 Jul 26, 2024	SELL	$21.22 - $32.66 $11.8 Million - $18.2 Million	-556,035 Reduced 6.8%	7,626,139 $179 Million
Q1 2024 Apr 18, 2024	SELL	$23.46 - $45.07 $28.4 Million - $54.6 Million	-1,211,715 Reduced 12.9%	8,182,174 $270 Million
Q4 2023 Jan 17, 2024	BUY	$17.69 - $30.76 $10.8 Million - $18.8 Million	609,998 Added 6.94%	9,393,889 $256 Million
Q3 2023 Oct 18, 2023	BUY	$23.01 - $32.46 $9.23 Million - $13 Million	401,296 Added 4.79%	8,783,891 $211 Million
Q2 2023 Jul 10, 2023	SELL	$29.32 - $35.99 $5.6 Million - $6.87 Million	-190,834 Reduced 2.23%	8,382,595 $268 Million
Q1 2023 Apr 17, 2023	BUY	$30.15 - $48.79 $10.9 Million - $17.6 Million	360,298 Added 4.39%	8,573,429 $263 Million
Q4 2022 Jan 24, 2023	SELL	$36.73 - $51.6 $10.2 Million - $14.3 Million	-277,805 Reduced 3.27%	8,213,131 $0
Q3 2022 Oct 17, 2022	SELL	$39.79 - $70.31 $12 Million - $21.2 Million	-301,128 Reduced 3.42%	8,490,936 $405 Million
Q2 2022 Jul 11, 2022	BUY	$29.86 - $62.36 $17.7 Million - $36.9 Million	591,315 Added 7.21%	8,792,064 $309 Million
Q1 2022 Apr 19, 2022	BUY	$53.73 - $82.16 $11.7 Million - $17.9 Million	217,348 Added 2.72%	8,200,749 $470 Million
Q4 2021 Jan 28, 2022	BUY	$68.02 - $99.06 $77.7 Million - $113 Million	1,141,679 Added 16.69%	7,983,401 $636 Million
Q3 2021 Nov 12, 2021	BUY	$84.37 - $133.6 $32.1 Million - $50.8 Million	380,355 Added 5.89%	6,841,722 $595 Million
Q2 2021 Aug 05, 2021	BUY	$64.12 - $128.71 $108 Million - $217 Million	1,682,263 Added 35.2%	6,461,367 $832 Million
Q1 2021 May 13, 2021	BUY	$71.28 - $120.75 $260 Million - $440 Million	3,647,481 Added 322.32%	4,779,104 $383 Million
Q4 2020 Feb 12, 2021	BUY	$22.24 - $95.63 $25.2 Million - $108 Million	1,131,623 New	1,131,623 $92.4 Million

Others Institutions Holding BEAM

# of Institutions

247

Shares Held

95.7M

Call Options Held

666K

Put Options Held

1.99M

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.19B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track Cathie Wood's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.

Account